Cardiometabolic Medicine

The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia.  These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.  

Our Tweetorials

Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.

@Cardiomet_CE on Twitter

Your only source for ACCREDITED SoMe-delivered 

serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!

On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME.  Programs are presented by expert faculty in engaging and fully interactive format.  Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.

Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.

cardio-met Follow

Your only source for JOINT-ACCREDITED SoMe-delivered, serialized professional cardiometabolic education. Physicians, nurses, pharmacists--come one, come all!

cardiomet_CE
cardiomet_ce cardio-met @cardiomet_ce ·
28 Jun

1) Welcome to our #accredited #tweetorial on Evaluating Post-Intervention Treatment Options for #PAD. Earn 0.5h #CME/CE credit for #physicians, #nurses, #nursepractitioners, #physicianassociates by following this🧵. Our expert author is Ritu Thamman MD @iamritu of @PittHealthSci.

Reply on Twitter 1541754923477508096 Retweet on Twitter 1541754923477508096 6 Like on Twitter 1541754923477508096 20 Twitter 1541754923477508096
Retweet on Twitter cardio-met Retweeted
vallealfonso Alfonso Valle @vallealfonso ·
22 Jun

Side effects and treatment initiation barriers of iSGLT2 👉systematic review & meta-analysis
👥10050 HFrEF
👉hypotension 4.5% on iSGLT2 vs 4.1% on placebo
👉Volume depletion 9.4% on SGLT2i
Vs 8.7% on placebo
👉AKI 1.9% iSGLT2 vs 2.8% placebo
#Flozinator @secardiologia

Reply on Twitter 1539616035212390401 Retweet on Twitter 1539616035212390401 35 Like on Twitter 1539616035212390401 83 Twitter 1539616035212390401
Load More